Currently, asymmetrical dimethyl arginine (ADMA) is considered a risk factor for cardiovascular diseases, and subsequent to its entry from blood vessels into the cell, it is metabolized largely by the enzyme dimethylarginine dimethylaminohydrolase (DDAH). The gene discussed is DDAH2; the disease is cardiovascular disorder.